Preventing Persistence of HPV Infection with Natural Molecules.
EGCG
HA
HPV infection
folic acid
persistence
vitamin B12
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
06 Mar 2023
06 Mar 2023
Historique:
received:
06
02
2023
revised:
26
02
2023
accepted:
03
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Human papillomavirus (HPV) infection is one the most common sexually transmitted infections worldwide. In most cases, the infection is temporary and asymptomatic; however, when persistent, it may lead to lesions that can evolve into cancer in both women and men. Nowadays, prophylactic vaccination is the primary preventive strategy for HPV infections, but vaccines do not cover all types of HPV strains. Scientific research has uncovered the beneficial role of some natural supplements in preventing persistent HPV infections or treating HPV-related lesions. We review the current insight into the roles of natural molecules in HPV infection with a special focus on epigallocatechin gallate (EGCG), folic acid, vitamin B12, and hyaluronic acid (HA). Specifically, EGCG from green tea extracts plays a critical role in suppressing HPV oncogenes and oncoproteins (E6/E7), which are responsible for HPV oncogenic activity and cancer development. Folic acid and vitamin B12 are essential vitamins for multiple functions in the body, and accumulating evidence suggests their importance in maintaining a high degree of methylation of the HPV genome, thus decreasing the likelihood of causing malignant lesions. HA, due to its re-epithelizing property, may prevent HPV virus entry in damaged mucosa and epithelia. Thereby, based on these premises, the combination of EGCG, folic acid, vitamin B12, and HA may be a very promising therapeutic approach to prevent HPV persistence.
Identifiants
pubmed: 36986338
pii: pathogens12030416
doi: 10.3390/pathogens12030416
pmc: PMC10056139
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Oncology (Williston Park). 1996 Nov;10(11):1727-36, 1742-3; discussion 1743-4
pubmed: 8953590
J Natl Cancer Inst. 2000 May 3;92(9):709-20
pubmed: 10793107
Medicina (Kaunas). 2022 May 09;58(5):
pubmed: 35630063
Aesthetic Plast Surg. 2019 Apr;43(2):480-489
pubmed: 30627811
J Biol Chem. 2000 Sep 8;275(36):27641-9
pubmed: 10882722
J Eur Acad Dermatol Venereol. 2011 Mar;25(3):345-53
pubmed: 21294779
Oncol Res. 2011;19(6):245-57
pubmed: 21776820
Cell Cycle. 2016 Sep;15(17):2231-2
pubmed: 27245825
Anal Biochem. 1983 Jul 1;132(1):6-13
pubmed: 6312838
Cancer. 1994 Aug 1;74(3):893-9
pubmed: 8039116
Plast Reconstr Surg Glob Open. 2019 May 01;7(5):e2221
pubmed: 31333952
Arch Gynecol Obstet. 2011 Jul;284(1):209-14
pubmed: 20740364
Cancer Causes Control. 2001 May;12(4):317-24
pubmed: 11456227
Oncogene. 2001 Nov 26;20(54):7874-87
pubmed: 11753670
Cancer Res. 2000 Nov 1;60(21):5916-21
pubmed: 11085503
N Engl J Med. 2007 May 10;356(19):1944-56
pubmed: 17494927
Cureus. 2020 Apr 8;12(4):e7586
pubmed: 32399320
Viruses. 2015 Jul 16;7(7):3863-90
pubmed: 26193301
Gynecol Oncol. 2004 Jan;92(1):197-204
pubmed: 14751158
Viruses. 2017 Sep 21;9(10):
pubmed: 28934151
Virus Res. 2017 Mar 2;231:21-33
pubmed: 27890631
Oncol Rep. 2010 Mar;23(3):605-14
pubmed: 20126997
PLoS One. 2012;7(10):e46749
pubmed: 23056433
Trends Immunol. 2005 Dec;26(12):637-43
pubmed: 16214414
Front Public Health. 2021 Jan 20;8:552028
pubmed: 33553082
Int J Cancer. 2015 Jun 15;136(12):2752-60
pubmed: 25043222
Am J Clin Nutr. 1982 Jan;35(1):73-82
pubmed: 7064879
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
pubmed: 16949997
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
Int J Gynecol Cancer. 2010 May;20(4):617-24
pubmed: 20686382
J Nutr. 2018 Mar 1;148(3):389-400
pubmed: 29546304
PLoS Pathog. 2017 Apr 6;13(4):e1006211
pubmed: 28384274
J Clin Virol. 2014 Sep;61(1):101-6
pubmed: 25011603
Epidemiol Infect. 2015 May;143(7):1442-50
pubmed: 25185457
Molecules. 2018 Sep 12;23(9):
pubmed: 30213130
Eur J Gynaecol Oncol. 2002;23(4):311-6
pubmed: 12214730
J Virol. 1987 Apr;61(4):1061-6
pubmed: 2434663
Genome Res. 2014 Feb;24(2):185-99
pubmed: 24201445
Eur J Cancer Prev. 2003 Oct;12(5):383-90
pubmed: 14512803
Int J Gynaecol Obstet. 2023 Feb;160(2):538-547
pubmed: 35810389
Adv Exp Med Biol. 1986;206:293-311
pubmed: 3591524
Biochem Biophys Res Commun. 2007 Sep 7;360(4):778-83
pubmed: 17624304
Int J Womens Health. 2010 Aug 09;2:7-12
pubmed: 21072292
Nutr Cancer. 2021;73(4):602-608
pubmed: 32794404
Lancet Oncol. 2005 Apr;6(4):204
pubmed: 15830458
J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1404-12
pubmed: 17958849
Res Integr Peer Rev. 2019 Mar 26;4:5
pubmed: 30962953
Pathogens. 2021 Apr 11;10(4):
pubmed: 33920477
Obstet Gynecol. 2008 Jun;111(6):1371-9
pubmed: 18515521
Asian Pac J Cancer Prev. 2012;13(9):4815-22
pubmed: 23167425
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3490-6
pubmed: 19959700
Nat Med. 2003 Jun;9(6):669-76
pubmed: 12778165
Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:2-13
pubmed: 28964706
Cold Spring Harb Symp Quant Biol. 1985;50:671-8
pubmed: 3007009
Nat Rev Cancer. 2007 Jan;7(1):11-22
pubmed: 17186016
ACS Appl Bio Mater. 2021 Jan 18;4(1):311-324
pubmed: 35014286
JAMA. 1992 Jan 22-29;267(4):528-33
pubmed: 1729576
Arch Pharm Res. 2009 Sep;32(9):1309-15
pubmed: 19784588
Nat Rev Cancer. 2021 Oct;21(10):607-608
pubmed: 34376828
Skin Res Technol. 2016 Feb;22(1):55-62
pubmed: 25877232
Int J Mol Sci. 2021 Feb 28;22(5):
pubmed: 33670861
Clin Exp Dent Res. 2022 Aug;8(4):858-862
pubmed: 35416411
Univ Mich Med Cent J. 1968;:255-9
pubmed: 5728249
J Nutr. 1999 Apr;129(4):779-82
pubmed: 10203550
Food Chem Toxicol. 2011 Dec;49(12):3281-6
pubmed: 21967781
Chem Biol Interact. 2015 Dec 5;242:380-9
pubmed: 26554336
Br J Dermatol. 2010 Jan;162(1):176-84
pubmed: 19709100
Int J Cancer. 2013 Sep 15;133(6):1271-85
pubmed: 22961444
Eur J Gynaecol Oncol. 1997;18(6):526-30
pubmed: 9443028
Cancer Surv. 1992;12:197-217
pubmed: 1322242
Sex Transm Dis. 2014 Nov;41(11):660-4
pubmed: 25299412
Mater Today Bio. 2021 Feb 25;11:100101
pubmed: 34036261
J Clin Pathol. 1994 Mar;47(3):253-6
pubmed: 7677803
Clin Invest Med. 2008;31(3):E106-16
pubmed: 18544273
Br J Dermatol. 2008 Jun;158(6):1329-38
pubmed: 18363746
J Infect Dis. 2001 Dec 15;184(12):1508-17
pubmed: 11740725
FASEB J. 1998 Nov;12(14):1491-7
pubmed: 9806758
Am J Epidemiol. 2008 Jul 15;168(2):123-37
pubmed: 18483125
Vaccine. 2012 Nov 20;30 Suppl 4:D1-83, vi
pubmed: 23510764
Cancer Res. 2004 Dec 1;64(23):8788-93
pubmed: 15574793
Nat Rev Cancer. 2004 Apr;4(4):253-65
pubmed: 15057285
Medicina (Kaunas). 2022 Jun 20;58(6):
pubmed: 35744098
Viruses. 2022 Oct 21;14(10):
pubmed: 36298863
Cancer Prev Res (Phila). 2014 Nov;7(11):1128-37
pubmed: 25145486
Invest New Drugs. 2010 Jun;28(3):216-24
pubmed: 19271153
Molecules. 2021 Jun 18;26(12):
pubmed: 34207319
Vaccine. 2006 Mar 30;24 Suppl 1:S16-22
pubmed: 16219398
Hum Vaccin Immunother. 2016 Mar 3;12(3):768-72
pubmed: 26383553